SKI Market

A+| A| A-|

Indian Indices

Sensex

76,991.22 790.54
( 1.04%)

Global Indices

Nasdaq

51,704.04 -29.67
(-0.06%)

Dow Jones

7,389.07 -104.72
(-1.40%)

Hang Seng

69,343.30 -445.08
(-0.64%)

Nikkei 225

10,453.87 25.02
(0.24%)

Forex

USD-INR

94.53 0.21
(0.22%)

EUR-INR

108.18 0.03
(0.03%)

GBP-INR

125.09 0.39
(0.31%)

JPY-INR

0.58 0.00
(0.06%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Fredun Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

539730

INE194R01017

489.430006

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

41.42

1375.64

EPS(TTM)

Face Value()

Div & Yield %

60.24

0.03

Particulars(INCOME)	Mar 2026 ( Cr)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)
Sales Turnover	635.47	453.82	348.16	274.68	224.46	133.89
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	635.47	453.82	348.16	274.68	224.46	133.89
Other Income	3.66	2.45	0.92	1.82	1.63	1.40
Stock Adjustments	31.69	-6.05	22.44	37.72	0.01	-1.17
Total Income	670.82	450.22	371.52	314.22	226.10	134.12
EXPENDITURE :
Raw Materials	480.76	321.89	282.42	245.57	176.45	100.60
Power & Fuel Cost	5.35	4.79	4.03	3.17	3.68	3.32
Employee Cost	32.94	22.23	12.50	11.54	10.66	8.66
Other Manufacturing Expenses	17.66	17.17	11.68	8.08	6.59	3.87
Selling & Administrative Expenses	36.72	26.42	20.77	14.55	12.76	7.80
Miscellaneous Expenses	2.59	2.63	1.22	1.71	0.46	0.28
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	576.02	395.12	332.61	284.62	210.60	124.54
Operating Profit	94.80	55.10	38.90	29.60	15.50	9.58
Interest	39.30	22.38	13.65	9.28	4.74	4.37
Gross Profit	55.50	32.72	25.25	20.32	10.76	5.21
Depreciation	7.91	4.45	3.80	2.81	2.16	2.00
Profit Before Tax	47.59	28.27	21.45	17.51	8.60	3.21
Tax	12.31	7.12	5.54	4.29	2.21	0.76
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	2.06	0.35	0.29	2.41	0.05	0.44
Reported Net Profit	33.21	20.81	15.62	10.81	6.34	2.01
Extraordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Net Profit	33.21	20.81	15.62	10.81	6.34	2.01
Adjustment below Net Profit	0.17	-20.81	-0.07	0.05	0.02	0.00
P & L Balance brought forward	63.91	63.91	28.55	18.00	11.93	10.18
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.33	0.00	0.33	0.31	0.28	0.27
P & L Balance carried down	96.95	63.91	43.77	28.55	18.00	11.93
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	7.00	7.00	7.00	7.00	7.00	7.00
Dividend Per Share(Rs)	0.70	0.70	0.70	0.70	0.70	0.70
Earnings Per Share-Unit Curr	60.68	44.07	33.25	23.84	14.29	5.05
Earnings Per Share(Adj)-Unit Curr	60.68	44.07	33.25	23.84	14.29	5.05
Book Value-Unit Curr	483.87	299.47	255.15	194.27	153.07	107.96
Book Value(Adj)-Unit Curr	483.87	299.47	255.15	194.27	153.07	107.96

76,991.22 790.54 ( 1.04%)

51,704.04 -29.67 (-0.06%)

7,389.07 -104.72 (-1.40%)

69,343.30 -445.08 (-0.64%)

10,453.87 25.02 (0.24%)

94.53 0.21 (0.22%)

108.18 0.03 (0.03%)

125.09 0.39 (0.31%)

0.58 0.00 (0.06%)